Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by MirrorWorldManon Jun 14, 2021 8:29pm
118 Views
Post# 33386203

RE:RE:RE:RE:We lost 1/2 our share price since launch..

RE:RE:RE:RE:We lost 1/2 our share price since launch..So many details were not released, many investors prior to launch were projecting 100ml tubes of skin lightener, thereby using 2g per tube. Instead we only see a 15 ml tube of targeted application on dark spots only, thats only .3 mg per tube! a little more that 15% of what was assumed to be the contents, hence 15% of the revenue projections. Sirona only gets $2.40/tube royalty on a $66 tube of Targeted Dark Spot Corrector, and 1067 is the active ingredient or 3.6% royalty.   Where is the skin Lightener cream  thats supposed to replace the toxic Hydroquinone for general purpose lightening in the asian population?
<< Previous
Bullboard Posts
Next >>